Figure 1From: Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor–positive, lymph-node–negative early-stage breast cancer in Japan Markov diagram. The level of recurrence risk is based on the 21-gene assay. Quotation marks indicate values unknown to physicians and patients. Abbreviation: aCT, adjuvant chemotherapy.Back to article page